U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07926737) titled 'CMT-133 in Healthy Adult Participants' on Oct. 23.
Brief Summary: This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CMT-133 in healthy adult participants after single or multiple doses. It is a randomized, double-blind, placebo-controlled, SAD and MAD study, which will be conducted in Parts A and B, respectively. CMT-133 will be administered via SC injection. Placebo will consist of normal saline administered via the same route (SC) and in a manner indistinguishable from active treatment.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adul...